original articlesgastrointestinal tumorsA phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients
gastrointestinal tumors
Under an Elsevier user license
open archive
Keywords
capecitabine
erlotinib
metastatic colorectal cancer
oxaliplatin
XELOX
Cited by (0)
Copyright © 2007 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.